Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate S1 capsule plus Cisplatin as adjuvant treatment in stageⅡ and Ⅲa non-small cell lung cancer. It is the first study in the world to investigate the safety and efficacy of S1 capsule using in stageⅡ and Ⅲa non-small cell lung cancer patients after the complete resection.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hebei Medical University Fourth Hospital
• Treatments: Cisplatin; Vinblastine; Vinorelbine

Criteria

Inclusion Criteria:

• Patient with completely resected stage ⅢA non-small cell lung cancer(NSCLC)

• Must be able to receive the therapy of the study within four weeks after the completely resection

Exclusion Criteria:

• Systemic anticancer treatment

• local radiotherapy